Affordable Access

deepdyve-link
Publisher Website

Vision-related quality of life in patients receiving intravitreal ranibizumab injections in routine clinical practice: baseline data from the German OCEAN study.

Authors
  • Bertelmann, Thomas1, 2
  • Feltgen, Nicolas3
  • Scheffler, Martin4
  • Hufenbach, Ulrich5
  • Wiedon, Annette6
  • Wilhelm, Helmut7
  • Ziemssen, Focke7
  • 1 Department of Ophthalmology, University Medical Center Goettingen, Robert-Koch-Straße 40, 37075, Goettingen, Germany. [email protected] , (Germany)
  • 2 Novartis Pharma GmbH, Nuremberg, Germany. [email protected] , (Germany)
  • 3 Department of Ophthalmology, University Medical Center Goettingen, Robert-Koch-Straße 40, 37075, Goettingen, Germany. , (Germany)
  • 4 MCR-Medical Center Rhauderfehn, Rhauderfehn, Germany. , (Germany)
  • 5 , Wernigerode, Germany. , (Germany)
  • 6 Novartis Pharma GmbH, Nuremberg, Germany. , (Germany)
  • 7 Centre for Ophthalmology, Eberhard-Karl University, Tuebingen, Germany. , (Germany)
Type
Published Article
Journal
Health and Quality of Life Outcomes
Publisher
Springer (Biomed Central Ltd.)
Publication Date
Sep 20, 2016
Volume
14
Issue
1
Pages
132–132
Identifiers
DOI: 10.1186/s12955-016-0536-1
PMID: 27644469
Source
Medline
Keywords
License
Unknown

Abstract

NCT02194803.

Report this publication

Statistics

Seen <100 times